Artificial intelligence model finds potential drug molecules

MIT researchers developed a geometric deep learning model that is more accurate and over 1,000 times faster at finding potential drug-like molecules than the fastest state-of-the-art computational models, reducing the chances and costs of failures in an industry where 90 percent of drug candidates fail clinical trials.

Related Keywords

Pat Walters , Artificial Intelligence Laboratory , Drug Administration , International Conference On Machine Learning , Collaborative Research , Department Of Electrical Engineering , Milky Way , International Conference , Machine Learning , Octavian Eugen Ganea , Abdul Latif Jameel Clinic , Jameel Clinic , Electrical Engineering , Computer Science , Pharmaceutical Discovery , Medical Countermeasures Against New , Molecular Discovery , Takeda Fellowship , World Through , Jameel Clinic For Machine Learning In Health , J Clinic , Sail , Achine Learning In Medicine , Drug Discovery , Geometric Deep Learning , Annes Stärk , Nternational Conference On Machine Learning Icml , Quibind , Quidock , Uickvina2 W , Ligands , Relay Therapeutics ,